Researcher
Joost Wauters
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Regenerative medicine, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory for Clinical Infectious and Inflammatory Disorders (Division)
Responsible
From1 Oct 2023 → Today - Processing Speech and Images (PSI) (Division)
Member
From1 Aug 2020 → 30 Jun 2000 - Laboratory of Intensive Care Medicine (Division)
Member
From1 Jan 2009 → 30 Sep 2011 - Laboratory for Clinical Infectious and Inflammatory Disorders (Division)
Member
From1 Dec 2004 → Today - ESAT - PSI, Processing Speech and Images (Division)
Member
From1 Nov 1999 → 30 Jun 2000 - Department of Electrical Engineering (ESAT) (Department)
Member
From1 Oct 1999 → 31 Jan 2000
Projects
11 - 20 of 21
- Development and streamlining a validation and implementation workflow for model-informed precision dosing for biologicals and antimicrobialsFrom1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
- Influenza-associated pulmonary aspergillosis: new perspectives on the pathophysiological and clinical aspects to enable host-directed medicineFrom30 Sep 2020 → TodayFunding: BOF - doctoral mandates, FWO fellowships
- Calming the storm: treating hypercoagulability and hyperinflammation in patients with COVID-19From22 May 2020 → 21 May 2021Funding: FWO thematic call for applied research
- Host directed medicine in invasive fungal infectionFrom1 Jan 2020 → TodayFunding: H2020 - Food security, sustainable agriculture, marine and maritime research and the bio-economy
- Unravelling the pathogenic mechanism behind influenza associated aspergillosisFrom25 Sep 2019 → TodayFunding: FWO fellowships
- Azithromycin for Chronic Obstructive Pulmonary Disease: A Patient-tailored PrescriptionFrom1 Aug 2019 → 17 Jan 2024Funding: FWO fellowships
- IPAFLU: A prospective study assessing the incidence of invasive pulmonary aspergillosis (IPA) and identifying host and microbial risk factors predisposing to IPA among critically ill patients with severe influenzaFrom1 Dec 2018 → 30 Nov 2020Funding: BOF - various
- Posaconazole (POS) prophylaxis for the management of infuenza-associated aspergillosis (IAA) in critically ill patientsFrom1 Oct 2018 → 30 Sep 2020Funding: IOF - Industrial Research Fund
- The co-pathogenesis of severe influenza and invasive pulmonary aspergillosis.From1 Oct 2017 → 30 Sep 2022Funding: FWO fellowships, BOF - Doctoral projects
- Antimicrobial dosing in critically ill patients with severe sepsis and septic shock: a novel patient-oriented and covariate driven approachFrom1 Oct 2016 → 30 Sep 2021Funding: FWO fellowships
Publications
1 - 10 of 139
- A good start is half the battle: Antibiotic IV line residuals in the intensive care unit.(2024)
Authors: Dorian Vanneste, Yves Debaveye, Joost Wauters
Pages: 103663 - Fungal Fog in Viral Storms: Necessity for Rigor in Aspergillosis Diagnosis and Research.(2024)
Authors: Simon Feys, Joost Wauters
Pages: 631 - 633 - Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study.(2024)
Authors: Simon Feys, Sam Vanmassenhove, Bram Boeckx, Seppe Cambier, Yves Debaveye, Greet Hermans, Katrien Lagrou, Johan Neyts, Marijke Peetermans, Joana Duarte Da Rocha Pereira, et al.
Pages: e247 - e260 - High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation(2024)
Authors: Simon Feys, Katrien Lagrou, Yves Debaveye, Greet Hermans, Johan Maertens, Marijke Peetermans, Robin Vos, Eric Van Wijngaerden, Alexander Wilmer, Joost Wauters
- Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature review(2024)
Authors: Dorian Vanneste, Matthias Gijsen, Johan Maertens, Wim Van Paesschen, Yves Debaveye, Joost Wauters
- Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment(2024)
Authors: Jannes Heylen, Johan Maertens, Joost Wauters
- Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series(2024)
Authors: Marijke Peetermans, Michael Casaer, Yves Debaveye, Stefanie Desmet, Greet Hermans, Joost Wauters
- Optimizing Azithromycin use in Respiratory Diseases: From COVID-19 to COPD “A comprehensive evaluation and Personalized Treatment Approach”(2024)
Authors: Iwein Gyselinck, Wim Janssens, Joost Wauters
- The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid(2024)
Authors: Jan Van Slambrouck, Lies Laenen, Xin Jin, Joost Wauters, Geert Molenberghs, Bart Vanaudenaerde, Robin Vos, Katrien Lagrou, Laurens Ceulemans
- Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies(2023)
Authors: Beatrijs Mertens, Joost Wauters, Yves Debaveye